(Press-News.org) DENVER/Sept. 6, 2023 — A newly funded study will evaluate both the frequency and major risk factors for cancer in golden retrievers, a breed commonly affected by the disease.
The study will use data from Morris Animal Foundation’s Golden Retriever Lifetime Study, which is one of the largest and most comprehensive canine health studies in the world. The study will also incorporate data from Veterinary Companion Animal Surveillance System (VetCompass), a not-for-profit research project based at the Royal Veterinary College in London, England. VetCompass collects and analyzes data from more than 1,800 veterinary practices in the United Kingdom.
“The evaluation of major risk factors for canine cancer can highlight potentially modifiable factors that could reduce the risk of cancer for future golden retrievers,” said David Brodbelt, epidemiologist and co-project leader of VetCompass. “This could include for example, certain lifestyle-related factors such as diet and levels of exercise.”
Moreover, by delving into cancer occurrences, not only in golden retrievers, but across the broader spectrum of dogs using VetCompass data, this research aims to put more intricate and precise findings from the Study into the context of the wider veterinary population, Brodbelt added.
This work is supported by a $10,000 sponsorship from Boehringer Ingelheim Animal Health USA Inc., an animal health pharmaceutical company. The sponsorship will support the hiring of a new canine cancer epidemiologist at the Royal Veterinary College who will lead cancer epidemiology research both at the college and within the study.
"Boehringer Ingelheim Animal Health is dedicated to providing solutions to unmet clinical needs in oncology,” said Dr. Marlene Hauck, Head of Oncology Research at Boehringer Ingelheim Animal Health USA Inc. “As such, this research will help determine the cancers that would benefit most from innovative therapeutic options.”
About Morris Animal Foundation
Morris Animal Foundation’s mission is to bridge science and resources to advance the health of animals. Founded in 1948 and headquartered in Denver, it is one of the largest nonprofit animal health research organizations in the world, funding nearly $160 million in more than 3,000 critical studies across a broad range of species. Learn more at morrisanimalfoundation.org.
About Boehringer Ingelheim Animal Health USA
Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock.
As a global leader in the animal health industry and as part of the family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well-being of both.
Boehringer Ingelheim Animal Health has deep roots in the U.S. from a start in St. Joseph, Missouri, more than 100 years ago, it has grown to encompass seven sites. Boehringer Ingelheim Animal Health’s portfolio contains widely used and well-respected vaccines, parasite-control products and therapeutics for pets, horses and livestock including NexGard®, Heartgard®, Pyramid® + Presponse®, VAXXITEK®, Ingelvac CircoFLEX® and Prascend®.
Learn more about Boehringer Ingelheim Animal Health USA at bi-animalhealth.com
Media Contact: Annie Mehl
END
Canine health data to guide new cancer study
2023-09-06
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Insomnia drug helps prevent oxycodone relapse, Scripps Research study shows
2023-09-06
LA JOLLA, CA—A good night’s sleep has many proven health benefits, and a new Scripps Research study suggests one more: preventing opioid relapse.
In the new study, published online in Neuropharmacology on August 12, 2023, scientists gave an experimental insomnia treatment to rats experiencing oxycodone withdrawal. The researchers found that the animals were far less likely to seek out drugs again in the future—even after ending the treatment. These findings could eventually lead to therapies to help prevent opioid addiction or relapse in humans.
“These results are very encouraging,” says Rémi Martin-Fardon, PhD, associate professor of molecular medicine ...
Disease affects blackbirds more than previously thought
2023-09-06
The researchers studied birds given a simulated bacterial infection in order to stimulate their immune system. The birds were then compared with birds whose immune system was not stimulated – and their activity was measured for several weeks using miniature data loggers.
“We found that the birds whose immune system was stimulated had reduced activity for three weeks, which is much longer than we expected. We could also see that the "sick" blackbirds stopped their activities ...
The António Champalimaud Vision Award 2023 distinguishes St John of Jerusalem Eye Hospital for their fight against blindness in Palestine
2023-09-06
The 2023 edition of the António Champalimaud Vision Award recognizes the St John of Jerusalem Eye Hospital Group (SJEHG) for its work supporting hundreds of thousands of people living in the Gaza Strip, West Bank and East Jerusalem, helping in the fight against blindness while providing access to essential health services in a region marked by conflict and instability.
The SJEHG has been developing its activity at the centre of three major world religions. The ongoing conflict in the region has had a severe impact on health care access and delivery. Without the intervention of the SJEHG, the rate of blindness would be rampant, increasing ...
CityU’s novel AI system enhances the predictive accuracy of autonomous driving
2023-09-06
Precisive real-time prediction of the movement of nearby vehicles or the future trajectory of pedestrians is essential for safe autonomous driving. A research team led by City University of Hong Kong (CityU) recently developed a novel AI system that improves predictive accuracy amid dense traffic and increases computational efficiency by over 85%, offering great potential for enhancing the safety of autonomous vehicles.
Professor Wang Jianping, in the Department of Computer Science (CS) at CityU, who led the study, explained the critical importance ...
Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult
2023-09-06
Study Title: Being Breastfed in Infancy and Risk of Colorectal Cancer and Precursor Lesions
Publication: Clinical Gastroenterology and Hepatology: https://www.cghjournal.org/article/S1542-3565(23)00673-0/fulltext
Dana-Farber Cancer Institute authors include Chen Yuan, ScD, first author; Kimmie Ng, MD, MPH, senior author
Summary: Rates of young-onset colorectal cancer have been on the rise since the early 1990s. This study, led by researchers at Dana-Farber Cancer Institute, investigated potential links between being breastfed as an infant and having colorectal cancer later in life. The team evaluated data collected by the Nurses’ Health Study ...
Study looking at how intermittent fasting and weight loss affect aging
2023-09-06
Studies have shown that intermittent fasting can help people lose weight and may be easier to follow than counting calories to lose weight, such as traditional calorie restriction. Exciting new research in animals suggests that intermittent fasting slows aging and helps animals live longer.
Researchers at the Pennington Biomedical Research Center and the University of Alabama at Birmingham are conducting a study to see if eating for 8 hours and fasting for 16 each day can slow the aging process in people and are looking for healthy adults aged 25-49 to participate.
In this study, called DiAL-Health, researchers will ...
New global climate restoration fund announces first grant cycle
2023-09-06
[Bethesda, Maryland, USA -- September 6] The new Climate Intervention Environmental Impact Fund (CIEIF, www.cieif.org) begins operations today, with the goal of helping kickstart new approaches to restoring Earth’s climate in the face of rapid deterioration. CIEF makes direct grants to investigators worldwide working to stop and reverse global warming. The grants are focused on predictive environmental impact assessments, impact modeling studies, and stakeholder engagement for proposed small-scale field tests of innovative climate intervention technologies. CIEIF also offers investigators expert advice on ...
IU researchers identify new gene mutation that alters Alzheimer’s disease risk
2023-09-06
INDIANAPOLIS—A groundbreaking study led by experts from Indiana University School of Medicine has shed new light on the genetic underpinnings of Alzheimer's disease. The team's research, rooted in human genetics studies, has unearthed a critical mutation within a key gene operating in the brain's immune cells, potentially elevating the risk of Alzheimer's disease.
The research team included several IU investigators within Stark Neurosciences Research Institute—Gary Landreth, PhD, the Martin Professor of Alzheimer’s Research; Bruce Lamb, PhD, executive director of Stark Neuroscience Research Institute; Stephanie Bissel, PhD, assistant ...
NIH investigates multidrug-resistant bacterium emerging in community settings
2023-09-06
New “hypervirulent” strains of the bacterium Klebsiella pneumoniae have emerged in healthy people in community settings, prompting a National Institutes of Health research group to investigate how the human immune system defends against infection. After exposing the strains to components of the human immune system in a laboratory “test tube” setting, scientists found that some strains were more likely to survive in blood and serum than others, and that neutrophils (white blood cells) are more likely to ingest and kill some strains than others. The study, published in mBio, was led by researchers at NIH’s National Institute of Allergy and Infectious Diseases (NIAID).
“This ...
Study reports discovery of new cell type in thymus
2023-09-06
RIVERSIDE, Calif. -- It came as a surprise to Professor David Lo and his graduate student Diana Del Castillo when they were recently consulted by researchers in Israel for their expertise on specialized cells called Microfold cells, or M cells, which are mostly known for their presence in the intestinal epithelium. The Israeli group had identified similar cells in the thymus, an organ located just above the heart that makes lymphocytes — white blood cells that play an important role in the immune system and protect the body against infection.
Lo, a distinguished professor of biomedical sciences in the UC Riverside School of Medicine, and Del Castillo, ...